title: ICR expands CanSAR drug discovery platform.
abstract: The UK's Institute of Cancer Research, London has broadened its CanSAR knowledgebase, a cancer drug-discovery platform that integrates genomic, chemical, and pharmacologic data. The newly released CanSAR 2.0 adds more prediction methodologies and holds data on more than 8 million experimentally derived measurements, nearly 1 million biologically active chemical compounds, and more than 1,000 cancer cell lines.
mesh_terms: D000970:Antineoplastic Agents; D016208:Databases, Factual; D055808:Drug Discovery; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy
chemical_list: D000970:Antineoplastic Agents